BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24697167)

  • 21. Formulation of lyophilized oily-core poly-Ɛ-caprolactone nanocapsules to improve oral bioavailability of Olmesartan Medoxomil.
    Khattab WM; Zein El-Dein EE; El-Gizawy SA
    Drug Dev Ind Pharm; 2020 May; 46(5):795-805. PubMed ID: 32275456
    [No Abstract]   [Full Text] [Related]  

  • 22. Ameliorating the antiparasitic activity of the multifaceted drug ivermectin through a polymer nanocapsule formulation.
    de Souza ZC; Júnior FHX; Pinheiro IO; de Souza Rebouças J; de Abreu BO; Mesquita PRR; de Medeiros Rodrigues F; Quadros HC; Mendes TMF; Nguewa P; Allegretti SM; Farias LP; Formiga FR
    Int J Pharm; 2023 May; 639():122965. PubMed ID: 37084836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
    Ravi PR; Vats R; Dalal V; Gadekar N; N A
    Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers.
    Murthy A; Ravi PR; Kathuria H; Malekar S
    Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation, biodistribution in rats of radiolabeled raloxifene.
    Bayrak E; Lambrecht FY; Durkan K; Yilmaz O
    Appl Radiat Isot; 2010 Jan; 68(1):33-6. PubMed ID: 19819155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability.
    Tran TH; Ramasamy T; Cho HJ; Kim YI; Poudel BK; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2014 Jul; 14(7):4820-31. PubMed ID: 24757949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysozyme and DNase I loaded poly (D, L lactide-co-caprolactone) nanocapsules as an oral delivery system.
    Abu Abed OS; Chaw C; Williams L; Elkordy AA
    Sci Rep; 2018 Sep; 8(1):13158. PubMed ID: 30177767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucoadhesive Amphiphilic Methacrylic Copolymer-Functionalized Poly(ε-caprolactone) Nanocapsules for Nose-to-Brain Delivery of Olanzapine.
    Fonseca FN; Betti AH; Carvalho FC; Gremião MP; Dimer FA; Guterres SS; Tebaldi ML; Rates SM; Pohlmann AR
    J Biomed Nanotechnol; 2015 Aug; 11(8):1472-81. PubMed ID: 26295147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of formulation variables for the preparation of poly(epsilon-caprolactone) nanocapsules containing the local anesthetic benzocaine.
    Moraes CM; de Matos AP; Grillo R; de Melo NF; de Paula E; Dias Filho NL; Rosa AH; Fraceto LF
    J Nanosci Nanotechnol; 2011 Mar; 11(3):2450-7. PubMed ID: 21449406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aceclofenac-loaded poly-epsilon-caprolactone nanocapsules. Effect of coadjuvants on morphometrical properties and drug entrapment.
    Alonso MJ; García ML; Espina M; Valls O; Egea MA
    Boll Chim Farm; 2000; 139(3):114-9. PubMed ID: 10961020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
    Limayem Blouza I; Charcosset C; Sfar S; Fessi H
    Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model.
    Ansari MD; Shafi S; Pandit J; Waheed A; Jahan RN; Khan I; Vohora D; Jain S; Aqil M; Sultana Y
    Drug Deliv Transl Res; 2024 Jun; 14(6):1635-1647. PubMed ID: 37996726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice.
    Dubey N; Shukla J; Hazari PP; Varshney R; Ganeshpurkar A; Mishra AK; Trivedi P; Bandopadhaya GP
    Hell J Nucl Med; 2012; 15(1):9-15. PubMed ID: 22413106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Green Nanotechnology in the Formulation of a Novel Solid Dispersed Multilayered Core-Sheath Raloxifene-Loaded Nanofibrous Buccal Film; In Vitro and In Vivo Characterization.
    Nageeb El-Helaly S; Abd-Elrasheed E; Salim SA; Fahmy RH; Salah S; El-Ashmoony MM
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33915828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.
    Mizuma T
    Int J Pharm; 2009 Aug; 378(1-2):140-1. PubMed ID: 19486934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly(ε-caprolactone)nanocapsules as carrier systems for herbicides: physico-chemical characterization and genotoxicity evaluation.
    Grillo R; dos Santos NZ; Maruyama CR; Rosa AH; de Lima R; Fraceto LF
    J Hazard Mater; 2012 Sep; 231-232():1-9. PubMed ID: 22795586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
    Zhang L; He Y; Ma G; Song C; Sun H
    Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
    Abdelwahed W; Degobert G; Fessi H
    Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity.
    Katzer T; Chaves P; Bernardi A; Pohlmann A; Guterres SS; Ruver Beck RC
    J Microencapsul; 2014; 31(6):519-28. PubMed ID: 24697184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.